Trials / Completed
CompletedNCT05452317
Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection
A Retrospective, Chart Review Study to Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection in the UK
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (actual)
- Sponsor
- CSL Behring · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates the burden of disease among kidney transplant recipients that have developed Chronic Active Antibody Mediated Rejection (caAMR) compared with kidney transplant recipients that have not developed caAMR
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Chronic active AMR group | Past kidney transplant. This is a retrospective, non-interventional, observational study. No study treatment will be administered in this study. |
| OTHER | Non-Chronic active AMR group | Past kidney transplant. This is a retrospective, non-interventional, observational study. No study treatment will be administered in this study. |
Timeline
- Start date
- 2022-07-14
- Primary completion
- 2023-04-04
- Completion
- 2023-04-04
- First posted
- 2022-07-11
- Last updated
- 2023-04-13
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05452317. Inclusion in this directory is not an endorsement.